Immune Checkpoint Inhibitors in Melanoma and HIV Infection

INTRODUCTION: Immunotherapy with immune checkpoint inhibitors increases the overall survival of patients with metastatic melanoma regardless of their oncogene addicted mutations. However, no data is available from clinical trials of effective therapies in subgroups of melanoma patients that carry ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Marra, Antonio, Scognamiglio, Giosuè, Peluso, Ilaria, Botti, Gerardo, Fusciello, Celeste, Filippelli, Amelia, Ascierto, Paolo A., Pepe, Stefano, Sabbatino, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730951/
https://www.ncbi.nlm.nih.gov/pubmed/29290886
http://dx.doi.org/10.2174/1874613601711010091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730951/
https://www.ncbi.nlm.nih.gov/pubmed/29290886
http://dx.doi.org/10.2174/1874613601711010091

Ejemplares similares